Assembly biosciences reports inducement grant under nasdaq listing rule 5635(c)(4)

South san francisco, calif., nov. 10, 2023 (globe newswire) -- assembly biosciences, inc. (nasdaq: asmb), a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today announced a grant of inducement awards to its chief medical officer, anuj gaggar, md, phd on november 8, 2023.
ASMB Ratings Summary
ASMB Quant Ranking